General

Bharat Biotech begins export

Author : NewsGram Desk

Bharat Biotech on Monday announced that it has commenced export of Covid-19 vaccine Covaxin.

Long Pending export orders have been executed during November, to be further expanded during the following months, the Hyderabad-based company said in a statement.

With the number of countries that have granted emergency use approvals for Covaxin increasing, exports to additional countries will also commence from December, it said.

The vaccine maker thanked the Government of India for approving exports. Covaxin will now become an integral part of the global fight against this pandemic, it added.

The company earlier said it was poised to achieve its goal of an annual capacity of about one billion doses of Covaxin by the end of 2021.

(IANS/JB)

Keywords: Bharat Biotech, Vaccines, Covaxin, India, Exports

Subscribe to our channels on YouTube and WhatsApp

Download our app on Play Store

Fee Collection Systems for Schools and Edtech

The Right to Nationality in Mozambique: The Application of ‘Jus Soli’ in the Fight Against Statelessness

‘West Indian by conviction’: The Caribbean Says Farewell to Poet and Author Ian McDonald

Taiwan tests Economic Leverage after Papua New Guinea closes Representative Office

Hundreds of Migrants From Morocco Reach Spain's Ceuta Enclave as Authorities Face Mounting Humanitarian Pressure